Oban BioPharma
1 known investors
Oban Biopharma develops allosteric GPCR-targeted therapeutics for metabolic and CNS/neuropsychiatric diseases, using computational structural and chemotype analysis combined with AI-based druggability filters to identify drug candidates. Its pipeline focuses on allosteric modulators of clinically validated GPCR targets intended to offer efficacy with fewer side effects than traditional orthosteric drugs.
Founders & leadership
DC
Derek ChalmersCo-founder, President & CEO, Board of Directors
ML
Michael LewisChief Scientific Officer, Board of Directors
Investors · 1
Competitors · 2
by search overlap
Abalone Bio4 shared keywordsAbalone Bio develops target-activating antibodies for difficult-to-drug disease targets by combining engineered biology with machine learning. The company uses large-scale biological measurement platforms and AI-powered sequence analysis to discover functional antibody drugs for pharmaceutical and biotechnology applications.
Abeona Therapeutics3 shared keywordsAbeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases with high unmet need, including its approved product ZEVASKYN and its lead PSMA-targeted T cell therapy ABO-701 for advanced prostate cancer. It uses ex vivo gene therapy, viral vector, and synthetic immune receptor T cell (SIR-T) technologies to serve patients with genetic diseases and solid tumors.
Companies competing with Oban BioPharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Oban BioPharma do?
- Oban Biopharma develops allosteric GPCR-targeted therapeutics for metabolic and CNS/neuropsychiatric diseases, using computational structural and chemotype analysis combined with AI-based druggability filters to identify drug candidates. Its pipeline focuses on allosteric modulators of clinically validated GPCR targets intended to offer efficacy with fewer side effects than traditional orthosteric drugs.
- Who founded Oban BioPharma?
- Oban BioPharma was founded by Derek Chalmers.
- Who are Oban BioPharma's investors?
- Oban BioPharma's investors include Connecticut Innovations.